188P Early mortality in atezolizumab/bevacizumab for unresectable hepatocellular carcinoma: European, real-world study.

Autor:	Ben Khaled, N.1 (AUTHOR), Jochheim, L.2 (AUTHOR), Boettcher, K.3 (AUTHOR), Scheiner, B.4 (AUTHOR), Sinner, F.5 (AUTHOR), Gairing, S.J.6 (AUTHOR), Alunni-Fabbroni, M.7 (AUTHOR), Thaler, M.8 (AUTHOR), Oecal, O.7 (AUTHOR), Anz, D.8 (AUTHOR), Ricke, J.9 (AUTHOR), Ehmer, U.10 (AUTHOR), Venerito, M.11 (AUTHOR), Foerster, F.12 (AUTHOR), Pinter, M.13 (AUTHOR), Mayerle, J.14 (AUTHOR), Geier, A.15 (AUTHOR), De Toni, E.N.14 (AUTHOR), Reiter, F.P.15 (AUTHOR), Piseddu, I.1 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 1, Vol. 35, pS84-S85. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu